Cita APA (7a ed.)

Canadian Agency for Drugs and Technologies in Health. (2018). Clinical review report Netupitant/palonosetron 300 mg/0.5 mg (Akynzeo) (Purdue Pharma). Canadian Agency for Drugs and Technologies in Health.

Cita Chicago Style (17a ed.)

Canadian Agency for Drugs and Technologies in Health. Clinical Review Report Netupitant/palonosetron 300 Mg/0.5 Mg (Akynzeo) (Purdue Pharma). Ottawa, Ontario: Canadian Agency for Drugs and Technologies in Health, 2018.

Cita MLA (9a ed.)

Canadian Agency for Drugs and Technologies in Health. Clinical Review Report Netupitant/palonosetron 300 Mg/0.5 Mg (Akynzeo) (Purdue Pharma). Canadian Agency for Drugs and Technologies in Health, 2018.